Cutera, Inc.  

(Public, NASDAQ:CUTR)   Watch this stock  
Find more results for CUTR
9.80
0.00 (0.00%)
Dec 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 9.72 - 10.13
52 week 8.06 - 11.82
Open 9.72
Vol / Avg. 134,674.00/26,380.00
Mkt cap 141.08M
P/E     -
Div/yield     -
EPS -0.65
Shares 14.40M
Beta 1.20
Inst. own 70%
Feb 9, 2015
Q4 2014 Cutera Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 2, 2014
Cutera Inc at Piper Jaffray Healthcare Conference
Nov 20, 2014
Cutera Inc at Canaccord Genuity Medical Technologies & Diagnostics Forum
Nov 3, 2014
Q3 2014 Cutera Inc Earnings Call - Webcast
Nov 3, 2014
Q3 2014 Cutera Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -14.08% -6.36%
Operating margin -13.56% -7.05%
EBITD margin - -5.30%
Return on average assets -9.95% -4.29%
Return on average equity -13.02% -5.42%
Employees 238 -
CDP Score - -

Address

3240 Bayshore Boulevard
BRISBANE, CA 94005
United States - Map
+1-415-6575500 (Phone)
+1-415-3302444 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Cutera, Inc. is a global medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and light-based aesthetics systems for practitioners worldwide. The Company offers products based on six platforms, which include CoolGlide, Xeo, Solera, GenesisPlus, Excel V, and myQ. Each of the Company's laser and light-based platforms consists of one or more hand pieces and a console that incorporates a graphic user interface, a laser or light-based module, control system software and high voltage electronics. In addition to systems and upgrades, the Company generates revenue from the sale of post warranty services, Titan hand piece refills, and Dermal filler and cosmeceuticals. Its CoolGlide, Xeo, Solera, GenesisPlus, Excel V and myQ platforms provide the benefits of laser and light-based aesthetic treatments. On February 2, 2012, it completed its acquisition of certain assets of IRIDEX Corporation´┐Żs (IRIDEX) global aesthetic business.

Officers and directors

Kevin P. Connors President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ronald J. Santilli Chief Financial Officer, Executive Vice President
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David A. Gollnick Vice President - North American Sales, Director
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David B. Apfelberg M.D. Lead Independent Director
Age: 72
Bio & Compensation  - Reuters
Gregory Barrett Independent Director
Age: 60
Bio & Compensation  - Reuters
W. Mark Mark Lortz Independent Director
Age: 62
Bio & Compensation  - Reuters
Timothy J. O'Shea Independent Director
Age: 61
Bio & Compensation  - Reuters
Jerry P. Widman CPA Independent Director
Age: 71
Bio & Compensation  - Reuters